Zobrazeno 1 - 10
of 17
pro vyhledávání: '"van de Velde ME"'
Autor:
Centanni M; Department of Pharmacy, Uppsala University, Box 580, 751 23, Uppsala, Sweden., van de Velde ME; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Uittenboogaard A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Kaspers GJL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Karlsson MO; Department of Pharmacy, Uppsala University, Box 580, 751 23, Uppsala, Sweden., Friberg LE; Department of Pharmacy, Uppsala University, Box 580, 751 23, Uppsala, Sweden. lena.friberg@farmaci.uu.se.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2024 Feb; Vol. 63 (2), pp. 197-209. Date of Electronic Publication: 2023 Dec 23.
Autor:
Uittenboogaard A; Pediatric oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van den Berg MH; Pediatric oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Abbink FCH; Pediatric oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Twisk JWR; Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., van der Sluis IM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pediatric Oncology, Erasmus Medical Center Rotterdam/Sophia Children's Hospital, Rotterdam, the Netherlands., van den Bos C; Pediatric oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Segers H; Department of Pediatric Hemato-Oncology, University Hospitals Leuven and Catholic University Leuven, Leuven, Belgium., Chantrain C; Department of Pediatrics, Clinique du MontLégia, The Centre Hospitalier Chrétien, Liège, Belgium., van der Werff Ten Bosch J; Department of Pediatric Onco-Hematology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Willems L; Department of Paediatric Haematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium., Kaspers GJL; Pediatric oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van de Velde ME; Pediatric oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Publikováno v:
Cancer medicine [Cancer Med] 2023 Oct; Vol. 12 (19), pp. 19480-19490. Date of Electronic Publication: 2023 Sep 21.
Autor:
van de Velde ME; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, 1081 HV Amsterdam, The Netherlands., Kaspers GJL; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, 1081 HV Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Abbink FCH; Emma Children's Hospital, Amsterdam UMC, Amsterdam Medical Center, Pediatric Oncology, 1105 AZ Amsterdam, The Netherlands., Twisk JWR; Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., van der Sluis IM; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Department of Pediatric Oncology, Erasmus Medical Center Rotterdam/Sophia Children's Hospital, 3000 CB Rotterdam, The Netherlands., van den Bos C; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Emma Children's Hospital, Amsterdam UMC, Amsterdam Medical Center, Pediatric Oncology, 1105 AZ Amsterdam, The Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Segers H; Department of Pediatric Hemato-Oncology, University Hospitals Leuven, 3000 Leuven, Belgium., Chantrain C; Department of Pediatrics, Clinique du MontLégia, CHC, 4000 Liège, Belgium., van der Werff Ten Bosch J; Department of Pediatric Onco-Hematology, Universitair Ziekenhuis Brussel, 1090 Brussels, Belgium., Willems L; Department of Paediatric Haematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, 9000 Ghent, Belgium., van den Berg MH; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, 1081 HV Amsterdam, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Feb 21; Vol. 15 (5). Date of Electronic Publication: 2023 Feb 21.
Autor:
Nijstad AL; Department of Clinical Pharmacy, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands. a.l.nijstad-2@umcutrecht.nl.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands. a.l.nijstad-2@umcutrecht.nl.; Department of Clinical Pharmacy, University Medical Center Utrecht, Internal postal D.00.204, Postbus 85500, 3508 GA, Utrecht, The Netherlands. a.l.nijstad-2@umcutrecht.nl., Chu WY; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands., de Vos-Kerkhof E; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Enters-Weijnen CF; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., van de Velde ME; Emma Children's Hospital, Pediatric Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, 1105 AZ, Amsterdam, The Netherlands., Kaspers GJL; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Emma Children's Hospital, Pediatric Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, 1105 AZ, Amsterdam, The Netherlands., Barnett S; Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK., Veal GJ; Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK., Lalmohamed A; Department of Clinical Pharmacy, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands.; Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, the Netherlands., Zwaan CM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Dr. Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands., Huitema ADR; Department of Clinical Pharmacy, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands.; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.
Publikováno v:
Pharmaceutical research [Pharm Res] 2022 Oct; Vol. 39 (10), pp. 2487-2495. Date of Electronic Publication: 2022 Aug 19.
Autor:
van de Velde ME; Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Uittenboogaard A; Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Yang W; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Bonten E; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Cheng C; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Pei D; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., van den Berg MH; Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands., van der Sluis IM; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., van den Bos C; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Emma Children's Hospital, Amsterdam UMC, Amsterdam Medical Center, Pediatric Oncology, 1105 Amsterdam, The Netherlands., Abbink FCH; Emma Children's Hospital, Amsterdam UMC, Amsterdam Medical Center, Pediatric Oncology, 1105 Amsterdam, The Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Segers H; Department of Pediatric Hemato-Oncology, University Hospitals Leuven and Catholic University Leuven, 3000 Leuven, Belgium., Chantrain C; Department of Pediatrics, Clinique du MontLégia, CHC, 4000 Liège, Belgium., van der Werff Ten Bosch J; Department of Pediatric Onco-Hematology, Universitair Ziekenhuis Brussel, 1090 Brussels, Belgium., Willems L; Department of Paediatric Haematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, 9000 Ghent, Belgium., Evans WE; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Kaspers GJL; Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Jul 19; Vol. 14 (14). Date of Electronic Publication: 2022 Jul 19.
Autor:
Uittenboogaard A; Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Academy and Outreach, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Njuguna F; Department of Child Health and Pediatrics, Moi University/Moi Teaching and Referral Hospital, Eldoret, Kenya., Mostert S; Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Academy and Outreach, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Langat S; Department of Child Health and Pediatrics, Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya., van de Velde ME; Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Olbara G; Department of Child Health and Pediatrics, Moi University/Moi Teaching and Referral Hospital, Eldoret, Kenya., Vik TA; Pediatric Hematology - Oncology, Indiana University School of Medicine, Indianapolis, Indiana, USA., Kaspers GJL; Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Academy and Outreach, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2022 Apr; Vol. 69 (4), pp. e29503. Date of Electronic Publication: 2021 Dec 15.
Autor:
Uittenboogaard A; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, 1105 AZ Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Neutel CLG; Department of Neurosurgery, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Ket JCF; Medical Library, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Njuguna F; Department of Pediatric Oncology, Moi University, Eldoret 30107, Kenya., Huitema ADR; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands., Kaspers GJL; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, 1105 AZ Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., van de Velde ME; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, 1105 AZ Amsterdam, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Jan 26; Vol. 14 (3). Date of Electronic Publication: 2022 Jan 26.
Autor:
van de Velde ME; Departments of Pediatric Oncology., El Hassani SEM; Pediatric Gastroenterology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam.; Department of Pediatric Gastroenterology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam., Kaspers GJL; Departments of Pediatric Oncology.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Broertjes J; Department of Pediatric Gastroenterology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam., Benninga MA; Department of Pediatric Gastroenterology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam., de Boer NKH; Department of Gastroenterology and Hepatology, Amsterdam UMC, Vrije Universiteit Amsterdam, AG&M Research Institute., Budding AE; inBiome BV, Amsterdam., de Meij TGJ; Pediatric Gastroenterology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam.
Publikováno v:
Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2022 Jan 01; Vol. 44 (1), pp. e152-e159.
Autor:
van de Velde ME; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, 1081 HV Amsterdam, The Netherlands.; Department of Pediatric Oncology/Hematology, Amsterdam UMC, 1081 HV Amsterdam, The Netherlands., den Bakker E; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Nephrology, 1081 HV Amsterdam, The Netherlands., Blufpand HN; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, 1081 HV Amsterdam, The Netherlands., Kaspers GL; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, 1081 HV Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Abbink FCH; Emma Children's Hospital, Amsterdam UMC, Amsterdam Medical Center, Pediatric Oncology, 1081 HV Amsterdam, The Netherlands., Kors AWA; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, 1081 HV Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Wilhelm AJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Clinical Pharmacology and Pharmacy, 1081 HV Amsterdam, The Netherlands., Honeywell RJ; Laboratory of Medical Oncology, Amsterdam University Medical Center, VUMC, 1081 HV Amsterdam, The Netherlands., Peters GJ; Laboratory of Medical Oncology, Amsterdam University Medical Center, VUMC, 1081 HV Amsterdam, The Netherlands.; Department of Biochemistry, Medical University of Gdansk, 80-210 Gdansk, Poland., Stoffel-Wagner B; Institute for Clinical Chemistry and Clinical Pharmacology, University of Bonn-Medical Center, 53127 Bonn, Germany., Buffart LM; Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Bökenkamp A; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Nephrology, 1081 HV Amsterdam, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Nov 26; Vol. 13 (23). Date of Electronic Publication: 2021 Nov 26.
Autor:
van de Velde ME; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric oncology, Amsterdam, The Netherlands., van den Berg MH; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric oncology, Amsterdam, The Netherlands., Kaspers GJL; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric oncology, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Abbink FCH; Emma Children's Hospital, Amsterdam UMC, Amsterdam Medical Center, Pediatric Oncology, Amsterdam, The Netherlands., Twisk JWR; Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., van der Sluis IM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van den Bos C; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Emma Children's Hospital, Amsterdam UMC, Amsterdam Medical Center, Pediatric Oncology, Amsterdam, The Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Segers H; Department of Pediatric Hemato-Oncology, UZ Leuven, Leuven, Belgium., Chantrain C; Department of Pediatrics, Clinique MontLégia, CHC, Liège, Belgium., van der Werff Ten Bosch J; Department of Pediatric Onco-Hematology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Willems L; Department of Paediatric Haematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium., van Litsenburg RRL; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric oncology, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Publikováno v:
Cancer medicine [Cancer Med] 2021 Nov; Vol. 10 (22), pp. 8172-8181. Date of Electronic Publication: 2021 Nov 01.